echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Nat Commun: Limiting eating time can reduce the risk of post-menotinal breast cancer

    Nat Commun: Limiting eating time can reduce the risk of post-menotinal breast cancer

    • Last Update: 2021-03-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Obesity is a serious health threat worldwide, and the incidence of obesity and metabolic syndrome has risen to epidemic levels over the past three decades, especially in Western countries.
    obesity and its associated metabolic disorders are type 2 diabetes, heart and kidney disease, and risk factors for at least 13 types of cancer, including post-menovascular breast cancer, colorectal cancer, endometrial cancer, esophageal adenocarcinoma and gallbladder cancer.
    recent studies have shown a strong association between obesity and breast cancer.
    previous studies have shown that calorie restriction can improve the harmful metabolic effects associated with obesity and inhibit cancer progression, but this intervention is difficult to implement and sustain outside the clinic.
    a recent study published in Nature Communications, researchers tested time-limited feeding (TRF) in models of obesity-driven post menotinal breast cancer mice.
    study showed that TRF inhibited the growth of obesity-enhanced breast tumors in both models without limiting calories or losing weight.
    TRF can also reduce the metastasis of breast cancer to the lungs.
    , in tumor gene model mice, TRF can delay tumor occurrence before obesity occurs.
    notable, TRF increases the sensitivity of insulin throughout the body, reduces high insulinemia, restores the circadian gene expression rhythm of tumors, and reduces tumor growth and insulin signaling.
    important, inhibiting insulin secretion with nitrosazole simulates TRF, while artificially raising insulin through an insulin pump can reverse the effects of TRF, which works by regulating high insulinemia.
    , these data suggest that TRF may be effective in the prevention and treatment of breast cancer.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.